Scott Tuten - Apr 18, 2022 Form 4 Insider Report for Danimer Scientific, Inc. (DNMR)

Role
Chief Marketing Officer
Signature
/s/ Scott Tuten
Stock symbol
DNMR
Transactions as of
Apr 18, 2022
Transactions value $
-$17,450
Form type
4
Date filed
4/20/2022, 04:09 PM
Previous filing
Mar 21, 2022
Next filing
May 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DNMR Class A Common Stock ("Common Stock") Options Exercise $32.8K +10K +1.98% $3.28 514K Apr 18, 2022 Direct F1
transaction DNMR Common Stock Sale -$50.3K -10K -1.95% $5.03 504K Apr 18, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DNMR Stock Option (right to purchase) Options Exercise $0 -10K -3.56% $0.00 271K Apr 18, 2022 Common Stock 10K $3.28 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 348,744 restricted shares of the Common Stock granted under a previously disclosed restricted stock award.
F2 This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Tuten on June 25, 2021. The Reporting Person exercised no discretion with respect to the sale. Proceeds from the sale were used to pay the exercise price of stock options, pursuant to a broker-assisted cashless exercise, and applicable withholding taxes.
F3 The options are fully vested and currently exercisable.